Drug

Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules

2 monthes ago   |   By Xconomy

Zentalis Pharmaceuticals is banking on small molecules for cancer-leaving the “cool technologies” aside for a “tried and true” approach, says the CEO, who wants to let the science speak for itself. Since it was founded five years ago, the company has moved three compounds into the clinic. How? By operating under the radar. “If you take away the outside distractions, which is what we've been doing; when you have that singular focus, which is to develop drugs, it really helps,” Zentalis Pharmaceuticals CEO Anthony Sun tells Xconomy. The company this week emerged from “stealth mode” after...
Read more ...

 


Search by Tags

   Drug      Clinical      Cancer      Pharmaceuticals      Science      Pharmaceutical      Drugs      National      National blog main      New York      New York blog main      San Diego      San Diego blog main      Biotech      Life Sciences      Oncology      Small molecules      Startups      Venture Capital      Zentalis Pharmaceuticals  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

IAmScience George Stewart

IAmScience George Stewart

By Becca Wolf | Bond LSC Medical bacteriologist, George Stewart has had a few stops along the way before he got to Bond LSC in 2004. Having done schooling and research at... Read more ...

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to tame high insulin... Read more ...

Senior Quality Engineer-Supplier - Abbott Rapid Diagnostics - San Diego, CA

Maintains the Supplier Audit Schedule and ensures compliance with this schedule. High level of attention to detail. APPLY DIRECTLY to be considered:From Indeed - Sun, 23 Feb... Read more ...

Comprehensive assessment of computational algorithms in predicting cancer...

The initiation and subsequent evolution of cancer are largely driven by a relatively small number of somatic mutations with critical functional impacts, so-called driver... Read more ...

A framework for transcriptome-wide association studies in breast cancer in...

The relationship between germline genetic variation and breast cancer survival is largely unknown, especially in understudied minority populations who often have poorer... Read more ...

Straightforward method for calibration of mechanistic cation exchange...

Abstract Mechanistic modeling of chromatography processes is one of the most promising techniques for the digitalization of biopharmaceutical process development. Possible... Read more ...

A Novel Approach to Evaluate ELISA Antibody Coverage of Host Cell Proteins ‐...

ABSTRACT Monitoring host cell proteins is one of the most important analytical requirements in production of recombinant biopharmaceuticals to ensure product purity and patient... Read more ...

Translational Science Clinical Expert - Viome - San Diego, CA

You will be a key clinical member of our Translational Science team focused on “translating” the rich omic data insights into nutrition recommendations for the...From Viome... Read more ...

FastMM: an efficient toolbox for personalized constraint-based metabolic...

Constraint-based metabolic modeling has been applied to understand metabolism related disease mechanisms, to predict potential new drug targets and anti-metabolites, and to... Read more ...

NucBreak: location of structural errors in a genome assembly by using...

Advances in whole genome sequencing strategies have provided the opportunity for genomic and comparative genomic analysis of a vast variety of organisms. The analysis results... Read more ...